11 – 20 of 3660
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Understanding RAMP1’s role in hormonal migraine may improve CGRP-targeted therapies
(2026) In Expert Review of Clinical Pharmacology
- Contribution to journal › Debate/Note/Editorial
-
Mark
When EVAR Fails, What Next? Balancing Risk, Durability, and Technique
(2026) In European Journal of Vascular and Endovascular Surgery
- Contribution to journal › Debate/Note/Editorial
-
Mark
Circulating Tumor DNA in Human Papilloma Virus-Positive Oropharyngeal Squamous Cell Carcinoma—Are We Ready to Individualize Treatment?
- Contribution to journal › Debate/Note/Editorial
-
Mark
First-line enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma—commentary on patient-reported outcomes in EV-302
- Contribution to journal › Debate/Note/Editorial
-
Mark
Governing through strain: Justice, Power and Resistance in an age of compounding crises
- Contribution to journal › Debate/Note/Editorial
-
Mark
The Around the Clock Terminology Consortium : A Global Consensus on Terminology to Discuss the 24-Hour Cycle of Physical Activity, Sedentary Behavior, and Sleep
- Contribution to journal › Debate/Note/Editorial
-
Mark
Editorial : Product lifetimes and the environment: Retaining product value in a circular economy
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reply to Zimhony and Yakovenko
- Contribution to journal › Debate/Note/Editorial
-
Mark
Vulnerable knowledge : Responding to the uncertainties of climate change-related disaster
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reply to Yaginuma, Seki and Shiraishi
- Contribution to journal › Debate/Note/Editorial
